Dr. Shin is a dual fellowship-trained (research, clinical) Hepatopancreatobiliary (HPB) surgical oncologist. Originally from Buffalo, NY, he attended Cornell University as an undergraduate, completing an A.B. in Economics, Phi Beta Kappa. He remained close to home for medical education in upstate New York at the University of Rochester, birthplace of the patient-centered, biopsychosocial paradigm in medical care. There, he became passionate about liver surgery as well as the History of Medicine. During his time as a medical student, he pursued additional Ph.D. level work in the history of medicine at Yale University, where his dissertation examined the origins of surgical anesthesia in pre-Civil War America. He returned to medical school and after graduation, continued pursuit of his passion for surgery at New York Presbyterian Hospital – Weill Cornell Medical Center for General Surgery Residency.
During his time in Manhattan, Dr. Shin was awarded a two-year post-doctoral research fellowship under the mentorship of William Jarnagin, Division Chief of Hepatopancreatobiliary Surgery at Sloan Kettering Research Institute, focusing on genomic and immunologic tumor biology research in primary and metastatic liver cancers. Owing to the close affiliation between Cornell and Memorial Sloan Kettering Cancer Center, he was able to secure additional clinical training and mentorship while a chief resident under the supervision of several world-renown faculty.
In the wake of COVID-19, Dr. Shin relocated to Santa Monica to pursue his Complex General Surgical Oncology (CGSO) fellowship at Saint John’s Cancer Institute — a fellowship born under the vision of Donald L. Morton, M.D. While a CGSO fellow, he continued to pursue and broaden his passion for HPB research and minimally invasive surgery.
Dr. Shin joins the faculty at Saint John’s Cancer Institute after graduating from its CGSO Fellowship, committed to delivering cutting edge, patient-centered care, whether minimally invasive robotic surgery or non-invasive liver directed therapy with ultrasound-based histotripsy therapy.
